Martine Zimmermann PharmD. is the Senior Vice President and Head of Global Regulatory Affairs at Alexion Pharmaceuticals. Based in Zurich, she has over 20 years of combined R&D and global regulatory strategy experience. She joined Alexion in 2009 and since then has been dedicated to the registration of Orphan Medical products as well as shaping a favorable regulatory environment for orphans. Throughout her career, Martine has been directly involved in multiple regulatory approvals across the globe and most recently Strensiq approval in 2015 in Japan, Europe and US. Martine received her Pharm D from University Louis Pasteur in Strasbourg (France).
WODC’s Rare Disease Day is a one-day event as part of the World Orphan Drug Congress
To sponsor or exhibit:
Michael Hodge
Michael.hodge@terrapinn.com
To speak:
Wing-Yun Cheung
wing-yun.cheung@terrapinn.com
Nadia Konneh
nadia.konneh@terrapinn.com